Turku Bioscience Centre
Contact Details
Persons
Publications
- A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-2a as first line treatment in metastatic melanoma (2010)
- A pH-Responsive Cluster Metal-Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (2022)
- A pH/temperature responsive nanocomposite for chemo-photothermal synergistic cancer therapy (2023)
- A Plasmid-Based Fluorescence Reporter System for Monitoring Oxidative Damage in E. coli (2022)
- Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines (2022)
- Application of ADA1 as a new marker enzyme in sandwich ELISA to study the effect of adenosine on activated monocytes (2016)
- Application of ZnO/CNT@Fe3O4 nanocomposite in amplifying the anti-leukemic effect of imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia (2021)
- Approximation Knob: Power Capping Meets Energy Efficiency (2016)
- A practical guide to single-cell RNA- sequencing for biomedical research and clinical applications (2017)
- A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer (2017)